This Special Issue of Molecules entitled "Advances in Photodynamic Therapy 2018" contains seven papers, including five original reports and two reviews. As befits a chemistry-based journal, most of the papers cover photosensitizer structure and function in photodynamic therapy (PDT).
The next paper [5] is a collaboration between laboratories from Jinan, China and Brasilia, Brazil. It reports the synthesis of five novel benzo[a]phenoxazinium chlorides as photosensitizers against 4T1 mouse breast cancer cells and NIH 3T3 mouse fibroblasts. One of the compounds was the first reported benzo[a]phenoxazinium dimer. The compounds showed a range of toxicity and phototoxicity towards cancer and normal cells, and the dimeric compound showed the most selective PDT killing of the cancer cells while sparing normal cells.
There follows a review paper [6] by the guest editor of the Special Issue, Michael R Hamblin, together with Heidi Abrahamse from Johannesburg in South Africa. It describes a series of studies from the Hamblin laboratory at the Wellman Center for Photomedicine at MGH in Boston, MA. These studies concern antimicrobial photodynamic inactivation using a range of different photosensitizers, and the potentiation of bacterial killing by a variety of inorganic salts. The paper concentrates on the different photochemical mechanisms that operate. For instance, sodium azide works by type I electron transfer to form azide radicals, while potassium iodide works via type II singlet oxygen reaction with iodide to form free iodine and iodine radicals. Potassium bromide only works with titanium dioxide photocatalysis. Sodium thiocyanate works via a combination of type II and type I pathways to form sulfur dioxide radical anions, while sodium selenocyanate works via the type II pathway to form selenocyanogen. Sodium nitrite appears to work via a type II mechanism to form peroxynitrate.
The last paper [7] is a comprehensive review paper with 229 references from the laboratory of Celine Frochot at the University of Lorraine in Nancy, France. The subject is the use of cyclodextrins (CD) in PDT. CD are naturally occurring cyclic oligosaccharides produced during the bacterial digestion of cellulose, which consist of between six and eight (α-1,4)-linked α-D-glucopyranose units. These vehicles are particularly effective at dissolving and disaggregating hydrophobic photosensitizers (PS) within the hydrophobic pocket of the CD. The review is divided into three parts covering the following: (1) non-covalent CD-PS inclusion complexes, covalent CD-PS conjugates, and CD-PS nanoassemblies; (2) incorporating CD-PS systems into hybrid nanoparticles (NP) using upconverting or other types of NP; and (3) CDs with fullerenes as PS.
